Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Spectrum & Other Psychotic Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02746510
What this trial is testing

Validation of a Clinical Screening Grid for Syndromic Schizophrenia

Who this might be right for
Schizophrenia
Hôpital le Vinatier 129
Not applicableStudy completedNCT00666146
What this trial is testing

Familial Schizophrenia and Spectrum Personality Disorders

Who this might be right for
Schizophrenia
University of Maryland, Baltimore 539
Not applicableLooking for participantsNCT05127278
What this trial is testing

E-Detection Tool for Emerging Mental Disorders

Who this might be right for
Psychosis
King's College London 3,000
Testing effectiveness (Phase 2)Study completedNCT00218218
What this trial is testing

Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia

Who this might be right for
Schizophrenia and Disorders With Psychotic FeaturesTobacco Use DisorderSchizophrenia
National Institute on Drug Abuse (NIDA) 48
Early research (Phase 1)Study completedNCT01620060
What this trial is testing

Lurasidone Pediatric Pharmacokinetics Study

Who this might be right for
SchizophreniaAutism
Sumitomo Pharma America, Inc. 105
Not applicableEnded earlyNCT03261817
What this trial is testing

A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders

Who this might be right for
SchizophreniaPhysical ActivitySchizo Affective Disorder
University Hospital, Caen 62
Post-approval studies (Phase 4)Study completedNCT00167817
What this trial is testing

Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot Study

Who this might be right for
Schizophrenia
Veterans Medical Research Foundation 15
Large-scale testing (Phase 3)Study completedNCT01714713
What this trial is testing

A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy

Who this might be right for
SchizophreniaImpaired Cognition
FORUM Pharmaceuticals Inc 830
Early research (Phase 1)Study completedNCT01948024
What this trial is testing

Bio-equivalence Study Between SAPHRIS and Asenapine

Who this might be right for
SchizophreniaBipolar Disorder
Sun Pharmaceutical Industries Limited 65
Not applicableStudy completedNCT07155096
What this trial is testing

Accelerated DMN-Targeted cTBS to Modulate DMN Connectivity

Who this might be right for
Schizophrenia
Vanderbilt University Medical Center 37
Early research (Phase 1)Study completedNCT06253546
What this trial is testing

Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia

Who this might be right for
Schizophrenia
Teva Branded Pharmaceutical Products R&D LLC 24
Large-scale testing (Phase 3)Ended earlyNCT00287742
What this trial is testing

The Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
Janssen Pharmaceutical K.K. 33
Not applicableStudy completedNCT03271242
What this trial is testing

Implementation of National Guidelines for Treatment of Psychoses

Who this might be right for
Psychotic Disorders
University Hospital, Akershus 325
Not applicableLooking for participantsNCT06155682
What this trial is testing

TMS for Inhibition Enhancement in Schizophrenia

Who this might be right for
Schizophrenia
University of Maryland, Baltimore 34
Post-approval studies (Phase 4)Study completedNCT00761670
What this trial is testing

Efficacy Study on Cognitive Functions in Schizophrenic Patients

Who this might be right for
Schizophrenia
Sanofi 37
Large-scale testing (Phase 3)Looking for participantsNCT07184619
What this trial is testing

Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia

Who this might be right for
Treatment-resistant Schizophrenia
Newron Pharmaceuticals SPA 400
Not applicableStudy completedNCT01731171
What this trial is testing

Probiotics to Prevent Relapse After Hospitalization for Mania

Who this might be right for
Bipolar DisorderSchizoaffective Disorder
Sheppard Pratt Health System 66
Post-approval studies (Phase 4)Study completedNCT00290121
What this trial is testing

Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics

Who this might be right for
Schizophrenia
Université de Montréal 25
Early research (Phase 1)Study completedNCT01892384
What this trial is testing

Safety and Tolerability of BI 409306 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Boehringer Ingelheim 40
Testing effectiveness (Phase 2)Study completedNCT02928965
What this trial is testing

The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms

Who this might be right for
Schizophrenia and Disorders With Psychotic Features
University of Manchester 207
Next Page